A subpopulation of CD133+ cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy

Cancer Letters

Volumn 289, Issue 2, 2010, Pages 151-160

  Zhang, Qunzhou ^a   Shi, Shihong ^a   Yen, Yun ^b   Brown, Jimmy ^c   Ta, Joseph Quoc ^d   Le, Anh D ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

CD133+ cancer stem like cell; Chemoresistance; Oral squamous cell carcinoma

Indexed keywords

BETA CATENIN; BREAST CANCER RESISTANCE PROTEIN; CD133 ANTIGEN; MESSENGER RNA; OCTAMER TRANSCRIPTION FACTOR 4; PACLITAXEL; TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTION FACTOR NANOG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CANCER INHIBITION; CANCER INVASION; CANCER RESISTANCE; CANCER STEM CELL; CARCINOGENESIS; CARCINOGENICITY; CELL SELECTION; CLONOGENESIS; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; FLOW CYTOMETRY; GROWTH INHIBITION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MOUTH CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGENS, CD; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; COLONY-FORMING UNITS ASSAY; DRUG RESISTANCE, NEOPLASM; FEMALE; FLOW CYTOMETRY; GLYCOPROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; MICE; MICE, NUDE; MOUTH NEOPLASMS; NEOPLASTIC STEM CELLS; PEPTIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 76849098162     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.08.010     Document Type: Article

References (48)

1. Parkin D.M., Bray F., Ferley J., and Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 55 (2005) 74-108
2. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., and Thun M.J. Cancer statistics, 2008. CA Cancer J. Clin. 58 (2008) 71-96
3. Sturgis E.M., and Cinciripini P.M. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers?. Cancer 110 (2007) 1429-1435
4. Shiboski C.H., Schmidt B.L., and Jordan R.C. Tongue and tonsil carcinoma: increasing trends in the US population ages 20-44 years. Cancer 103 (2005) 1843-1849
5. Jemal A., Siegel R., Ward E., Murray T., Xu J., and Thun M.J. Cancer statistics, 2007. CA Cancer J. Clin. 57 (2007) 43-66
6. Singh S.K., Clarke I.D., Terasaki M., Bonn V.E., Hawkins C., Squire J., and Dirks P.B. Identification of a cancer stem cell in human brain tumors. Cancer Res. 63 (2003) 5821-5828
7. Dalerba P., Cho R.W., and Clarke M.F. Cancer stem cells: models and concepts. Annu. Rev. Med. 58 (2007) 267-284
8. Chen J.S., Pardo F.S., Wang-Rodrihuez J., Chu T.S., Lopez J.P., Aguilera J., Altuna X., Weisman R.A., and Ongkeko W.M. EGFR regulates the side population in head and neck squamous cell carcinoma. Laryngoscope 116 (2006) 401-406
9. Prince M.E., Sivanandan R., Kaczorowski A., Wolf G.T., Kaplan M.J., Dalerba P., Weissman I.L., Clarke M.F., and Ailles L.E. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc. Natl. Acad. Sci. USA 104 (2007) 973-978
10. Zhou L., Wei X., Cheng L., Tian J., and Jiang J.J. CD133, one of the markers of cancer stem cells in Hep-2 cell line. Laryngoscope 117 (2007) 455-460
11. Wang J., Guo L.P., Chen L.Z., Zeng Y.X., and Lu S.H. Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line. Cancer Res. 67 (2007) 3716-3724
12. Mackenzie I.C. Growth of malignant oral epithelial stem cells after seeding into organotypical cultures of normal mucosa. J. Oral Pathol. Med. 33 (2004) 71-78
13. Locke M., Heywood M., Fawell S., and Mackenzie I.C. Retention of intrinsic stem cell hierarchies in carcinoma derived cell lines. Cancer Res. 65 (2005) 8944-8950
14. Costea D.E., Tsinkalovsky O., Vintermyr O.K., Johannessen A.C., and Mackenzie I.C. Cancer stem cells - new and potentially important targets for the therapy of oral squamous cell carcinoma. Oral Dis. 12 (2006) 443-454
15. Zhou S., Schuetz J.D., Bunting K.D., Colapietro A.M., Sampath J., Morris J.J., Lagutina I., Grosveld G.C., Osawa M., Nakauchi H., and Sorrentino B.P. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat. Med. 7 (2001) 1028-1034
16. Ho M.M., Ng A.V., Lam S., and Hung J.Y. Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res. 67 (2007) 4827-4833
17. Dubrovska A., Kim S., Salamone R.J., Walker J.R., Maira S.-M., Garcia-Echeverria C., Schultz P.G., and Reddy V.A. The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations. Proc. Natl. Acad. Sci. USA 106 (2009) 268-273
18. + prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 25 (2006) 696-1708
19. + cell population is enriched in tumor-initiating cells. Cancer Res. 67 (2007) 6796-6805
20. Chen W., Guomin W., Yujun L., and Ruizhe Q. Cancer stem-like cells in human prostate carcinoma cells DU145: the seeds of the cell line?. Cancer Biol. Ther. 6 (2007) 763-768
21. Stingl J., Eirew P., Ricketson I., Shackleton M., Vaillant F., Choi D., Li H.I., and Eaves C.J. Purification and unique properties of mammary epithelial stem cells. Nature 439 (2006) 993-997
22. Al-Hajj M., Wicha M.S., BenitoHernandez A., Morrison S.J., and Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 100 (2003) 3983-3988
23. + breast cancer-initiating cells to radiation. J. Natl. Cancer Inst. 98 (2006) 1777-1785
24. Li C.W., Heidt D.G., Dalerba P., Burant C.F., Zhang L., Adsay V., Wicha M., Clarke M.F., and Simeone D.M. Identification of pancreatic cancer stem cells. Cancer Res. 67 (2007) 1030-1037
25. Zheng X., Shen G., Yang X., and Liu W. Most C6 cells are cancer stem cells: evidence from clonal and population analyses. Cancer Res. 67 (2007) 3691-3697
26. Chiou S.H., Yu C.C., Huang C.Y., Lin S.C., Liu C.J., Tsai T.H., Chou S.H., Chien C.S., Ku H.H., and Lo J.F. Positive correlation of Oct-4 and nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin. Cancer Res. 14 (2008) 4085-4095
27. Yin S., Li J., Hu C., Chen X., Yao M., Yan M., Jiang G., Ge C., Xie H., Wan D., Yang S., Zheng S., and Gu J. CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int. J. Cancer 120 (2007) 444-1450
28. Zhang Q., Tang X., Zhang Z.-F., Velikina R., Shi S., and Le A. Nicotine induces hypoxia-inducible factor-expression in human lung cancer cells via nicotinic acetylcholine receptor-mediated signaling pathways. Clin. Cancer Res. 13 (2007) 4686-4694
29. Huang G.S., Lopez-Barcons L., Freeze B.S., Smith A.B., Goldberg G.L., Horwitz S.B., and McDaid H.M. Potentiation of taxol efficacy by discodermolide in ovarian carcinoma xenograft-bearing mice. Clin. Cancer Res. 12 (2006) 298-304
30. Hambardzumyan D., Squatrito M., and Holland E.C. Radiation resistance and stem-like cells in brain tumors. Cancer Cell 10 (2006) 454-456
31. Giordano A., Fucito A., Romano G., and Marino I.R. Carcinogenesis and environment: the cancer stem cell hypothesis and implications for the development of novel therapeutics and diagnostics. Front Biosci. 12 (2007) 3475-3482
32. Bao S., Wu Q., McLendon R.E., Hao Y., Shi Q., Hjelmeland A.B., Dewhirst M.W., Bigner D.D., and Rich J.N. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444 (2006) 756-760
33. Hermann P.C., Huber S.L., Herrler T., Aicher A., Ellwart J.W., Guba M., Bruns C.J., and Heeschen C. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1 (2007) 313-323
34. Eramo A., Lotti F., Sette G., Pilozzi E., Biffoni M., Di Virgilio A., Conticello C., Ruco L., Peschle C., and De Maria R. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 15 (2008) 504-514
35. Levina V., Marrangoni A.M., DeMarco R., Gorelik E., and Lokshin A.E. Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties. PLoS One 3 (2008) e3077
36. Szotek P.P., Pieretti-Vanmarcke R., Masiakos P.T., Dinulescu D.M., Connolly D., Foster R., Dombkowski D., Preffer F., Maclaughlin D.T., and Donahoe P.K. Ovarian cancer side population defines cells with stem cell-like characteristics and mullerian inhibiting substance responsiveness. Proc. Natl. Acad. Sci. USA 103 (2006) 11154-11159
37. Dalerba P., Dylla S.J., Park I.K., Liu R., Wang X., Cho R.W., Hoey T., Gurney A., Huang E.H., Simeone D.M., Shelton A.A., Parmiani G., Castelli C., and Clarke M.F. Phenotypic characterization of human colorectal cancer stem cells. Proc. Natl. Acad. Sci. USA 104 (2007) 10158-10163
38. O'Brien C.A., Pollett A., Gallinger S., and Dick J.E. A human colon cancer cell capable of initiating tumor growth in immunodeficient mice. Nature 445 (2007) 06-110
39. Todaro M., Alea M.P., Di Stefano A.B., Cammareri P., Vermeulen L., Iovino F., Tripodo C., Russo A., Gulotta G., Medema J.P., and Stassi G. Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 1 (2007) 389-402
40. + hepatocellular carcinoma cells as cancer stem/progenitor cells. Biochem. Biophys. Res. Commun. 351 (2006) 820-824
41. Schatton T., Murphy G.F., Frank N.Y., Yamaura K., Waaga-Gasser A.M., Gasser M., Zhan Q., Jordan S., Duncan L.M., Weishaupt C., Fuhlbrigge R.C., Kupper T.S., Sayegh M.H., and Frank M.H. Identification of cells initiating human melanomas. Nature 451 (2008) 345-349
42. Shmelkov S.V., St Clair R., Lyden D., and Rafii S.. AC133/CD133/prominin-1. Int. J. Biochem. Cell. Biol. 37 (2005) 715-719
43. Rich RN R.N., and Bao S.D. Chemotherapy and cancer stem cells. Cell Stem Cell 1 (2007) 353-355
44. Woodward W.A., Chen M.S., Behbod F., Alfaro M.P., Buchholz T.A., and Rosen J.M. Wnt/β-catenin mediates radiation resistance of mouse mammary progenitor cells. Proc. Natl. Acad. Sci. USA 104 (2007) 618-623
45. Ma S., Chan K.W., Hu L., Lee T.K., Wo J.Y., Ng I.O., Zheng B.J., and Guan X.Y. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Hepatology 132 (2007) 2542-2556
46. Dean M., Fojo T., and Bates S. Tumor stem cells and drug resistance. Nat. Rev. Cancer 5 (2005) 275-284
47. Wang J.C.Y. Evaluating therapeutic efficacy against cancer stem cells: new challenges posed by a new paradigm. Cell Stem Cell 1 (2007) 497-501
48. + HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway. Oncogene 27 (2008) 1749-1758